FDA Warning Letter — Acorda Therapeutics, Inc.

Case 406158 — FEI 3002457563

The FDA took a Warning Letter action against Acorda Therapeutics, Inc. on Jul 25, 2013 (Pearl River, NY). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Acorda Therapeutics, Inc.
Date
Jul 25, 2013
Fiscal Year
2013
Product Type
Drugs
Center
CDER
Location
Pearl River, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.